Evidence map›Paper›PMID 31913116›Full record

ArticleeLife2020

A genome-wide view of the de-differentiation of central nervous system endothelial cells in culture.

Mark F Sabbagh, Jeremy Nathans

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Development of the blood-brain barrier.Development (Cambridge, England) · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Frontiers in pharmacology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Mark F SabbaghDepartment of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, United States.ORCID 0000-0003-1996-5251
Jeremy NathansDepartment of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, United States.ORCID 0000-0001-8106-5460
Howard Hughes Medical Institute · USJohns Hopkins University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007309 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI COX, ANDREA L · 1985 to 2019
$43.2M
The control of retinal vascular development by Norrin and Frizzled4R01EY018637 · NEI · JOHNS HOPKINS UNIVERSITY · PI NATHANS, JEREMY · 2008 to 2021
$5.5M
Cell Competition in the Developing Mammalian Central Nervous System VasculatureF30HD088023 · NICHD · JOHNS HOPKINS UNIVERSITY · PI SABBAGH, MARK FARES · 2016 to 2018
$147k
Howard Hughes Medical InstituteNEI NIH HHS R01 EY018637NICHD NIH HHS F30 HD088023NIGMS NIH HHS T32 GM007309
6 · The paper itself

Abstract

Vascular endothelial cells (ECs) derived from the central nervous system (CNS) variably lose their unique barrier properties during in vitro culture, hindering the development of robust assays for blood-brain barrier (BBB) function, including drug permeability and extrusion assays. In previous work (Sabbagh et al., 2018) we characterized transcriptional and accessible chromatin landscapes of acutely isolated mouse CNS ECs. In this report, we compare transcriptional and accessible chromatin landscapes of acutely isolated mouse CNS ECs versus mouse CNS ECs in short-term in vitro culture. We observe that standard culture conditions are associated with a rapid and selective loss of BBB transcripts and chromatin features, as well as a greatly reduced level of beta-catenin signaling. Interestingly, forced expression of a stabilized derivative of beta-catenin, which in vivo leads to a partial conversion of non-BBB CNS ECs to a BBB-like state, has little or no effect on gene expression or chromatin accessibility in vitro.

Indexed as

Cell DifferentiationTranscription, GeneticAnimalsbeta CateninBlood-Brain BarrierCentral Nervous SystemChromatinEndothelial CellsGenomeMaleMiceMice, Transgenicbeta CateninChromatinCTNNB1 protein, mousebeta-cateninblood-brain barriercell culturechromatinendothelialgeneticsgenomicsmouseneuroscienceWnt

Identifiers

PMID31913116
PMCPMC6948952
OpenAlexW2999402088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.